We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
29 Aug 2020 - 02 Sep 2020
Virtual Venue

Innovative Cannulas Allow Fast Bone Marrow Draws

By HospiMedica International staff writers
Posted on 17 Jun 2015
Print article
Image: The Bio-MAC bone marrow aspiration catheter drawing form the tibia (Photo courtesy of Biologic Therapies).
Image: The Bio-MAC bone marrow aspiration catheter drawing form the tibia (Photo courtesy of Biologic Therapies).
New power driven bone marrow cannulas avoid causing patients painful bone microfractures during the extraction process.

The Biologic Therapies Bio-MAC bone marrow aspiration cannula and the Bio-CORE bone marrow biopsy cannula are minimally invasive devices that are inserted into bone using any standard surgical drill. The cannulas are available in multiple lengths for use throughout the anatomy, thus adding the iliac crest, lumbar vertebral body, tibia, humerus, and calcaneus as viable sites for bone marrow aspiration. Since the process is minimally invasive, a local anesthesia is sufficient to carry out the procedure in the physicians own office.

The Bio-MAC’s cannula contains eight large, smooth, bevel-edged fenestrations, which allow for gentle bone marrow aspiration. A plunger component inserted down the cannula creates a void where bone marrow pools, resulting in higher aspiration efficiency and an easier draw. The Bio-CORE cannula’s distal tip geometry, on the other hand, eliminates concentrated pressure and heat at the aspiration site, and also allows for easy removal of the marrow sample from the cannula, without damage.

For concentrating the bone marrow extracts, the company also offers the AutoSpin, a fully automated dual spin centrifuge that can be programmed to deliver a volume of 3–10 mL from each processing cycle. Since it is a closed system, the AutoSpin also dramatically reduces the chance for contamination. The centrifuge is compatible with two separate convenience kits containing all components needed to process bone marrow aspirate concentrate (BMAC) or platelet-rich plasma (PRP). Both cannulas and centrifuge are products of Biologic Therapies (Ocala, FL, USA), and have been approved by the US Food and Drug Administration (FDA).

“The ability to aspirate a patient’s marrow, concentrate the marrow in a centrifuge to derive the maximum number of regenerative cells and growth factors, and then give the concentrated cells and growth factors back to the patient in a physician’s office makes regenerative cell therapy a much easier, more available, and less costly procedure,” said Wade McKenna, MD, chief medical director of Biologic Therapies.

Related Links:

Biologic Therapies



Print article

Channels

Business

view channel
Illustration

Siemens to Acquire Varian Medical to Create Comprehensive Cancer Portfolio

Siemens Healthineers (Erlangen, Germany) has entered into an agreement to acquire Varian Medical Systems, Inc. (Palo Alto, CA, USA) that will lead to the creation of a global leader in healthcare with... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.